DIA Biosimilars 2013

University of Maryland

University of Maryland Ventures partners with life sciences companies

Thursday, August 15, 2013 09:02 AM

University of Maryland (UM) Ventures has announced agreements between University of Maryland, Baltimore (UMB) and five different life sciences companies across the Baltimore/Washington metropolitan region: Rexahn Pharmaceuticals, Plasmonix, IGI Technologies, A&G Pharmaceuticals and BioAssay Works.

More... »

Cenduit: Now with Patient Reminders

FDA awards $2 million to support CERSI

Thursday, October 27, 2011 01:23 PM

The FDA has reported the award of $2 million to support two regional Centers of Excellence in Regulatory Science and Innovation (CERSI).

More... »

CRF Health – eCOA Forum

University of Maryland receives $23 million for HIV vaccine

Friday, May 6, 2011 12:23 PM

Scientists at the University of Maryland School of Medicine will be able to move forward on decades-long work for a promising HIV/AIDS vaccine after receiving $23.4 million from a consortium led by The Bill & Melinda Gates Foundation, according to The Baltimore Sun.

More... »

Streamlining IRB approval process yields dramatic results in turnaround time for University of Maryland

Monday, April 25, 2011 08:02 AM

Last March it took 35 days for a full Institutional Review Board (IRB) approval for a clinical trial from the University of Maryland’s School of Medicine, which reviews more than 1,000 applications annually. This March, IRB approval time dropped to 21 days, and just 13 days in February.

More... »

Mersana initiates phase Ib of lead cancer drug

Tuesday, March 29, 2011 12:54 PM

Massachusetts-based Mersana Therapeutics announced the initiation of a phase 1b extension study with its lead cancer product, XMT-1001, a novel DNA topoisomerase I inhibitor based on the company's Fleximer polymer conjugate platform, in second-line gastric cancer and second-/third-line non-small cell lung cancer.  The study will be carried out in 10 clinical centers in the U.S. 

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.